EA201400940A1 - Способ получения медетомидина - Google Patents

Способ получения медетомидина

Info

Publication number
EA201400940A1
EA201400940A1 EA201400940A EA201400940A EA201400940A1 EA 201400940 A1 EA201400940 A1 EA 201400940A1 EA 201400940 A EA201400940 A EA 201400940A EA 201400940 A EA201400940 A EA 201400940A EA 201400940 A1 EA201400940 A1 EA 201400940A1
Authority
EA
Eurasian Patent Office
Prior art keywords
medetomidine
getting
dimethylbenzene
bromo
acetone
Prior art date
Application number
EA201400940A
Other languages
English (en)
Other versions
EA025950B1 (ru
Inventor
Флоренсио Сарагоса Дёрвальд
Анна Кулеша
Штефан Эльцнер
Роберт Буйок
Збигнев Вробель
Кшиштов Войцеховски
Original Assignee
Лонца Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47558543&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201400940(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/EP2012/070870 external-priority patent/WO2012172119A2/en
Application filed by Лонца Лтд. filed Critical Лонца Лтд.
Publication of EA201400940A1 publication Critical patent/EA201400940A1/ru
Publication of EA025950B1 publication Critical patent/EA025950B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

В изобретении раскрыт способ получения медетомидина исходя из 1-бром 2,3-диметилбензола и ацетона.
EA201400940A 2012-05-08 2012-11-15 Способ получения медетомидина EA025950B1 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261644284P 2012-05-08 2012-05-08
EP12167134 2012-05-08
PCT/EP2012/070870 WO2012172119A2 (en) 2012-05-08 2012-10-22 Method for the preparation of medetomidine
EP12192612 2012-11-14
PCT/EP2012/072796 WO2013011155A2 (en) 2012-05-08 2012-11-15 Method for preparation of medetomidine

Publications (2)

Publication Number Publication Date
EA201400940A1 true EA201400940A1 (ru) 2015-01-30
EA025950B1 EA025950B1 (ru) 2017-02-28

Family

ID=47558543

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201400940A EA025950B1 (ru) 2012-05-08 2012-11-15 Способ получения медетомидина

Country Status (20)

Country Link
US (1) US9045433B2 (ru)
EP (1) EP2847173B1 (ru)
JP (1) JP5779297B2 (ru)
KR (1) KR101530506B1 (ru)
CN (1) CN104245679B (ru)
AU (1) AU2012285675B2 (ru)
CA (1) CA2866424A1 (ru)
CL (1) CL2014002905A1 (ru)
CY (1) CY1117490T1 (ru)
DK (1) DK2847173T3 (ru)
EA (1) EA025950B1 (ru)
ES (1) ES2563816T3 (ru)
HR (1) HRP20160215T1 (ru)
HU (1) HUE027384T2 (ru)
IN (1) IN2014DN07983A (ru)
MY (1) MY166058A (ru)
PL (1) PL2847173T3 (ru)
SG (1) SG11201405606RA (ru)
TW (1) TWI529164B (ru)
WO (1) WO2013011155A2 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2557638T3 (es) 2012-05-08 2016-01-27 Lonza Ltd Método para la preparación de 2-(2,3-dimetilfenil)-1-propanal
IN2014DN07983A (ru) * 2012-05-08 2015-05-01 Lonza Ag
JP5777841B2 (ja) * 2012-06-28 2015-09-09 ロンザ・リミテッド クロロアセトンを用いてメデトミジンを調製するための方法
IN2014DN08121A (ru) * 2012-06-28 2015-05-01 Lonza Ag
CN106518812A (zh) * 2016-10-25 2017-03-22 湖南大学 一种美托咪定及其中间体的制备方法
CN111548308A (zh) * 2020-03-18 2020-08-18 遂成药业股份有限公司 一种盐酸右美托咪定的合成工艺
KR102341174B1 (ko) * 2021-09-13 2021-12-20 주식회사 세라수 양이온교환 섬유를 사용한 테레프탈릴리덴 디캠퍼 설폰산염의 산성화 방법
CN114671811A (zh) * 2022-04-14 2022-06-28 南京正科医药股份有限公司 一种右美托咪定拆分副产物的外消旋化回收方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790604A (fr) 1971-10-28 1973-04-26 Sandoz Sa Nouveaux aminoalcanols, leur preparation et leur application comme medicaments
JPS51100042A (en) 1975-02-26 1976-09-03 Kanebo Ltd 22 * 44 isobuchirufueniru * puropionsanno seizoho
JPS51100041A (en) 1975-02-26 1976-09-03 Kanebo Ltd 22 * 44 isobuchirufueniru * puropionsanno seizoho
GB2092569B (en) 1981-02-05 1984-09-19 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB2101114B (en) 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
DE3586403T2 (de) 1984-02-24 1993-02-04 Sagami Chem Res Methode zum isomerisieren eines glycidats.
JPS62103037A (ja) * 1985-10-29 1987-05-13 Hamari Yakuhin Kogyo Kk ２−（４−イソブチルフエニル）−プロピオンアルデヒドの製造法
DE19714042A1 (de) 1997-04-05 1998-10-08 Henkel Kgaa Verfahren zur Herstellung aromatischer Aldehyde
SE513474C2 (sv) 1999-01-25 2000-09-18 Hans Elwing Instutionen Foer C Metod för att förhindra kräftdjurs, särskilt havstulpaners, etablering på fasta ytor med hjälp av en substans som stör nervsignaler, varvid substansen är medetomidin, dvs (+)-4-/1- (2,3-dimetylfenyl)-etyl/-IH-imidazol
EP1918282A1 (en) 2006-11-06 2008-05-07 "Joint Stock Company Grindeks" Method for preparing medetomidine and its salts
GB2453982B (en) * 2007-10-24 2009-09-16 Norbrook Lab Ltd Chemical process for the preparation of Medetomidine
US7902247B2 (en) 2008-01-09 2011-03-08 Allergan, Inc. Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors
CN102753532B (zh) 2009-12-09 2015-05-13 I-技术有限公司 美托咪定的制备方法
IN2014DN07983A (ru) * 2012-05-08 2015-05-01 Lonza Ag
ES2557638T3 (es) * 2012-05-08 2016-01-27 Lonza Ltd Método para la preparación de 2-(2,3-dimetilfenil)-1-propanal
WO2012172120A2 (en) 2012-05-08 2012-12-20 Lonza Ltd 2-(2,3-dimethylphenyl)-1-propanal and its use as perfume
WO2012172119A2 (en) * 2012-05-08 2012-12-20 Lonza Ltd Method for the preparation of medetomidine
IN2014DN08121A (ru) 2012-06-28 2015-05-01 Lonza Ag
WO2012172122A2 (en) * 2012-06-28 2012-12-20 Lonza Ltd Method for the preparation of 2-(2,3-dimethylphenyl)-1-propanal
JP5777841B2 (ja) 2012-06-28 2015-09-09 ロンザ・リミテッド クロロアセトンを用いてメデトミジンを調製するための方法
WO2012172121A1 (en) * 2012-06-28 2012-12-20 Lonza Ltd Method for the preparation of medetomidine with chloroacetone

Also Published As

Publication number Publication date
ES2563816T3 (es) 2016-03-16
CN104245679A (zh) 2014-12-24
EP2847173A2 (en) 2015-03-18
DK2847173T3 (en) 2016-04-04
IN2014DN07983A (ru) 2015-05-01
KR20140136523A (ko) 2014-11-28
MY166058A (en) 2018-05-22
US9045433B2 (en) 2015-06-02
EP2847173B1 (en) 2015-12-30
HRP20160215T1 (hr) 2016-03-25
US20150057453A1 (en) 2015-02-26
CN104245679B (zh) 2016-03-02
CA2866424A1 (en) 2013-01-24
WO2013011155A2 (en) 2013-01-24
TWI529164B (zh) 2016-04-11
NZ700640A (en) 2016-03-31
AU2012285675B2 (en) 2016-03-03
SG11201405606RA (en) 2014-11-27
HK1201532A1 (zh) 2015-09-04
WO2013011155A3 (en) 2013-04-04
PL2847173T3 (pl) 2016-06-30
JP2015517472A (ja) 2015-06-22
EA025950B1 (ru) 2017-02-28
TW201408648A (zh) 2014-03-01
CY1117490T1 (el) 2017-04-26
JP5779297B2 (ja) 2015-09-16
CL2014002905A1 (es) 2014-12-12
HUE027384T2 (en) 2016-10-28
KR101530506B1 (ko) 2015-06-19
AU2012285675A1 (en) 2014-10-16

Similar Documents

Publication Publication Date Title
CY1122398T1 (el) Συνδυαστικες θεραπειες με αντισωματα anti-cd38
MX377710B (es) Anticuerpos monoclonales contra bcma.
EA201591750A1 (ru) Антитела против b7-h4 и иммуноконъюгаты
UY4153Q (es) Batería
CO7151527A2 (es) Anticuerpos anti-cd79 b e inmunoconjugados
UY34763A (es) Inhibidores de la agregación plaquetaria
UY34817A (es) Tienopirimidinas
IN2014DN05885A (ru)
DK3135668T3 (da) Ny disubstitueret 1,2,4-triazin-forbindelse
EA201400940A1 (ru) Способ получения медетомидина
CY1117492T1 (el) Μεθοδος για την παρασκευη μεδετομιδινης με χλωροακετονη
EA201600026A1 (ru) Бактериальная гиалуронидаза и способ ее производства
WO2014145897A3 (en) Immunotherapy system and method thereof
UY4430S (es) “motocicleta”.
CL2015002358A1 (es) Compuestos bicíclicos.
CY1117404T1 (el) Μεθοδος παρασκευης 2-(2,3-διμεθυλφαινυλ)-1-προπαναλης
AR097668A1 (es) Colorante-polímero
UY34677A (es) Imidazopiridazinas sustituidas
UY4152Q (es) Batería
BR112015002575A2 (pt) processamento submarino.
UY4237Q (es) Taburete
EA201201647A1 (ru) Способ получения f-18 меченных лигандов бета-амилоида
MX2015010789A (es) Anticuerpos anti-pcsm.
UY34291A (es) Indicador de humedad de cobre, almidón y yoduro
UY33207A (es) Métodos de preparación de tiazolidinas

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU